Palatin Technologies, Inc. (LON:0KF3)
London · Delayed Price · Currency is GBP · Price in USD 9.61
+0.40 (4.34%)
Jul 22, 2026, 2:34 PM GMT
Palatin Technologies Market Cap
Palatin Technologies has a market cap or net worth of 12.78 million as of July 27, 2026. Its market cap has increased by 132.11% in one year.
Market Cap
12.78M
Enterprise Value
5.40M
Revenue
9.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.61
ChartMarket Cap Chart
Since January 29, 2018, Palatin Technologies's market cap has decreased from 124.07M to 12.78M, a decrease of -89.70%. That is a compound annual growth rate of -23.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 12.78M | -63.65% |
| Dec 11, 2025 | 35.16M | 61.85% |
| Dec 31, 2024 | 21.72M | -43.72% |
| Dec 29, 2023 | 38.60M | 99.29% |
| Dec 28, 2022 | 19.37M | -79.00% |
| Dec 30, 2021 | 92.25M | -28.03% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SkinBioTherapeutics | 30.45M |
| ImmuPharma | 28.08M |
| Arecor Therapeutics | 23.98M |
| IXICO | 18.53M |
| Aptamer Group | 16.41M |
| Fusion Antibodies | 13.44M |
| Genflow Biosciences | 10.76M |
| Cizzle Biotechnology Holdings | 8.71M |